The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus
Open accessAbstract
Insulin resistance in non-insulin-dependent diabetes is associated with a defective insulin activation of the enzyme glycogen synthase in skeletal muscles. To investigate whether this may be a primary defect, we studied 20 young (25 +/- 1 yr) Caucasian first-degree relatives (children) of patients with non-insulin-dependent diabetes, and 20 matched controls without a family history of diabetes. Relatives and controls had a normal oral glucose tolerance, and were studied by means of the euglycemic hyperinsulinemic clamp technique, which included performance of indirect calorimetry and muscle biopsies. Insulin-stimulated glucose disposal was decreased in the relatives (9.2 +/- 0.6 vs 11.5 +/- 0.5 mg/kg fat-free mass per (FFM) min, P less than 0.02), and was due to a decreased rate of insulin-stimulated nonoxidative glucose metabolism (5.0 +/- 0.5 vs 7.5 +/- 0.4 mg/kg fat-free mass per min, P less than 0.001). The insulin-stimulated, fractional glycogen synthase activity (0.1/10 mmol liter glucose-6-phosphate) was decreased in the relatives (46.9 +/- 2.3 vs 56.4 +/- 3.2%, P less than 0.01), and there was a significant correlation between insulin-stimulated, fractional glycogen synthase activity and nonoxidative glucose metabolism in relatives (r = 0.76, P less than 0.001) and controls (r = 0.63, P less than 0.01). Furthermore, the insulin-stimulated increase in muscle glycogen content over basal values was lower in the relatives (13 +/- 25 vs 46 +/- 9 mmol/kg dry wt, P = 0.05). We conclude that the defect in insulin activation of muscle glycogen synthase may be a primary, possibly genetically determined, defect that contributes to the development of non-insulin-dependent diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [31]
Experimental — accuracy not yet measuredIn the citing paper
“The ability of insulin to stimulate glycogen synthase also is diminished in the normal glucose-tolerant, insulin-resistant relatives of type 2 diabetic individuals [218].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
Defronzo, R., Deibert, D., Hendler, R., Felig, P., & Soman, V. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109394 · Cited by 188
RetractedPROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Calculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365
Assessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,604
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,198
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Research works printed but not linked: 2
- [26]26. Bergman, R. N., I. D. Hope, Y. J. Yang, R. M. Watanabe, M. A. Meador, J. H. Youn, and M. Ader. 1989. Assessment ofinsulin sensitivity in vivo: a critical review. Diabetes Metab. Rev. 5:411-429.
- [28]28. Lowry, 0. H., and J. V. Passoneau. 1972. A Flexible System ofEnzymatic Analysis. Academic Press, Inc., New York.
Cited by
Sorted by citations
Items 101–200 of 296
Genetics of type 2 diabetes mellitus: status and perspectives
Hansen, L. B., & Pedersen, O. B. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00396.x · Cited by 61
H�ring, H. U., & Mehnert, H. (1993) · Diabetologia · doi:10.1007/bf00399946 · Cited by 60
“An abnormality of glycogen synthase activation is likely to be a very early event in the development of Type 2 diabetes as this abnormality has been reported in the prediabetic state [ 14-16 , 69].”
Rossetti, L., & Hu, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116919 · Cited by 60
Vaag, A. A., ALFORD, F. P., Henriksen, F. L., Christopher, M., & Beck‐Nielsen, H. (1995) · Diabetologia · doi:10.1007/bf00400638 · Cited by 58
“Before the biochemical analysis the muscle samples were freeze-dried and dissected free of visible connective tissue, fat and blood [5, 7, 14, 16].”
BackgroundMethodInfluentialSelf-citationFrederiksen, C. M., Højlund, K., Hansen, L., Oakeley, E. J., Hemmings, B., Abdallah, B. M., Brusgaard, K., Beck-Nielsen, H., & Gaster, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1122-9 · Cited by 57
“Consistently, impaired insulin activation of phosphatidylinositol 3-kinase and glycogen synthase has been demonstrated in muscle of patients with type 2 diabetes [2,10], their first-degree relatives [ 6 ] and diabetic myotubes [7, 8, 11, 12].”
BackgroundMethodHuang, X., Vaag, A. A., Hansson, M., Weng, J., Laurila, E., & Groop, L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6535 · Cited by 63
Self-citationHandberg, A., Vaag, A. A., Vinten, J., & Beck‐Nielsen, H. (1993) · Diabetologia · doi:10.1007/bf00404079 · Cited by 57
“Calculations of glucose kinetics were performed as previously described [14].”
BackgroundMethodInfluentialSelf-citationInsulin Signaling Defects in Type 2 Diabetes
Leng, Y., Karlsson, H., & Zierath, J. R. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021432.84588.f6 · Cited by 54
“In normal glucose-tolerant relatives of type 2 diabetic patients, insulin resistance in skeletal muscle has been observed several years before the development of overt diabetes [ 3 ].”
BackgroundStorgaard, H., Jensen, C. B., Björnholm, M., Song, X. M., Madsbad, S., Zierath, J. R., & Vaag, A. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031243 · Cited by 57
Self-citationChang, P.-Y., MARCHAND‐BRUSTEL, Y. L., Cheatham, L. A., & Moller, D. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29928 · Cited by 48
7 Insulin action and substrate competition
Groop, L., & Ferrannini, E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80243-5 · Cited by 51
Yang, Z., Miyahara, H., Iwasaki, Y., Takeo, J., & Katayama, M. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-16 · Cited by 52
An, P., Teran-Garcia, M., Rice, T., Rankinen, T., Weisnagel, S. J., Bergman, R. N., Boston, R. C., Mandel, S., Stefanovski, D., Leon, A. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1769-4 · Cited by 54
“The storage of glucose as glycogen in human skeletal muscles is frequently impaired in patients with type 2 diabetes and their non-diabetic relatives, partially because of impaired activation of the GYS1 gene by insulin [29].”
BackgroundVaag, A. A., Lehtovirta, M., Thye‐Rønn, P., & Groop, L. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00496.x · Cited by 46
Self-citationYang, M., Chen, P., Jin, H., Xie, X., Gao, T., Yang, L., & Yu, X. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-133 · Cited by 46
“Indeed, significant defects of insulin sensitivity, as well as of β-cell dysfunction, are present decades before first-degree relatives (FDRs) of T2DM develop the disease [4,5].”
BackgroundInoue, I., Takahashi, K., Katayama, S., Harada, Y., Negishi, K., Itabashi, A., & Ishii, J. (1995) · Metabolism · doi:10.1016/0026-0495(95)90085-3 · Cited by 45
Ekstrand, A., Schalin‐Jäntti, C., fman, M. L., Parkkonen, M., Wid�n, E., Franssila-Kallunki, A., Saloranta, C., Koivisto, V. A., & Groop, L. (1996) · Transplantation · doi:10.1097/00007890-199603270-00008 · Cited by 42
A paired-sibling analysis of the XbaI polymorphism in the muscle glycogen synthase gene
Orho‐Melander, M., Almgren, P.-E., Kanninen, T., Forsblom, C. M., & Groop, L. (1999) · Diabetologia · doi:10.1007/s001250051282 · Cited by 42
Beck‐Nielsen, H., Nielsen, O. H., Vaag, A. A., & ALFORD, F. P. (1994) · Diabetologia · doi:10.1007/s001250050097 · Cited by 42
“Of interest, basal HGP [22, 23] and the inhibitory effect of insulin on HGP was found to be normal in these subjects, indicating that the primary (genetic?) insulin resistance must be located in skeletal muscles and not in the liver [24].”
BackgroundSelf-citationHyperandrogenicity in women—a prediabetic condition?
Björntorp, P. A. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb01016.x · Cited by 40
Jun, H., Bae, H. Y., Lee, B. R., Koh, K. S., Kim, Y., Lee, K. W., Kim, H., & Yoon, J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00071-4 · Cited by 40
Pak, Y., Hong, Y., Kim, S., Piccariello, T., Farese, R. V., & Larner, J. (1998) · Molecules and Cells · doi:10.1016/s1016-8478(23)13428-5 · Cited by 42
Hansen, L., Arden, K. C., Rasmussen, S., Viars, C. S., Vestergaard, H., Hansen, T. F., Møller, A. M., Woodgett, J. R., & Pedersen, O. B. (1997) · Diabetologia · doi:10.1007/s001250050771 · Cited by 39
Bajaj, M., Medina-Navarro, R., Suraamornkul, S., Meyer, C., DeFronzo, R. A., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-0840 · Cited by 38
“Such individuals, who have two or more primary relatives with type 2 diabetes, are characterized by insulin resistance, increased plasma FFAs, and decreased insulin signaling in skeletal muscle (33,34).”
BackgroundShimomura, H., Sanke, T., Ueda, K., Hanabusa, T., Sakagashira, S., & Nanjo, K. (1997) · Diabetologia · doi:10.1007/s001250050772 · Cited by 36
“Several recent studies have shown reduced insulin-stimulated GYS1 activity in skeletal muscle of NIDDM patients [2–6] and their first-degree relatives with normal glucose tolerance [3, 6, 7].”
BackgroundInteractions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1 · Cited by 37
Qi, Z., Xia, J., Xue, X., He, Q., Ji, L., & Ding, S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.005 · Cited by 37
“In addition, previous studies reported that insulin resistance decreased activation of glycogen synthase in skeletal muscle in young nonobese patients with type 2 diabetes [60].”
BackgroundGlintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37
“womenwithPCOSsimilartootherpopulationscharacterizedby insulin resistance and impaired insulin-stimulated NOGM such as patients with type 2 diabetes (6–8, 14, 31), their FDR ( 9 , 10, 11),patientswithHIV-associatedlipodystrophy(28),McArdles disease (32), carriers of a mutant IR (33), and obese nondiabetic subjects (8,…”
BackgroundSelf-citationDela, F., & Stallknecht, B. M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00765.2009 · Cited by 37
Ortmeyer, H. K., Bodkin, N. L., & HANSEN, B. C. (1994) · Diabetologia · doi:10.1007/s001250050082 · Cited by 37
“non-insulin-dependent diabetes [20], first-degree relatives of patients with non-insulin-dependent diabetes compared to normal subjects [20, 21], non-insulin-de-”
BackgroundResultThe Etiology and Pathogenesis of Non-insulin-dependent Diabetes
Groop, L., & Eriksson, J. G. (1992) · Annals of Medicine · doi:10.3109/07853899209167000 · Cited by 36
Østergård, T., Jessen, N., Schmitz, O., & Mandarino, L. J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-031 · Cited by 36
“Decreased insulin stimulation of nonoxidative glucose disposal, or glycogen synthesis, is the main defect that quantitatively explains the decrease in insulin-stimulated glucose uptake (Eriksson et al. 1989; Nyholm et al. 1996; Vaag et al. 1992).”
BackgroundInfluentialCharacterization of the Prediabetic State
Groop, L. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00149-0 · Cited by 37
Samocha‐Bonet, D., Heilbronn, L. K., Lichtenberg, D. A., & Campbell, L. V. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.09.008 · Cited by 36
Guerrero‐Romero, F., & Rodríguez‐Morán, M. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.06.003 · Cited by 34
Højbjerre, L., Sonne, M. P., Alibegovic, A. C., Dela, F., Vaag, A. A., Meldgaard, J. B., Christensen, K. B., & Stallknecht, B. M. (2010) · Diabetes · doi:10.2337/db10-0320 · Cited by 40
“Type 2 diabetes has a major hereditary component (4), and FDR subjects show multiple abnormalities in intermediary metabolism and pancreatic islet cell function, displaying insulin resistance despite normal glucose tolerance (5).”
BackgroundSelf-citationOsei, K., & Cottrell, D. A. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02029.x · Cited by 35
Gillberg, L., Jacobsen, S., Ribel‐Madsen, R., Gjesing, A. P., Boesgaard, T. W., Ling, C., Pedersen, O. B., Hansen, T. F., & Vaag, A. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058384 · Cited by 34
“Indeed, significant defects of peripheral (muscle) and hepatic insulin action, as well as of pancreatic beta cell function, have been reported to be present decades before first degree relatives (FDR) of patients with T2D are supposed to develop the disease [3,4].”
Self-citationHenriksen, J. E., Alford, F., Vaag, A., Handberg, A., & Beck-Nielsen, H. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90126-9 · Cited by 33
Self-citationProteomics of Skeletal Muscle: Focus on Insulin Resistance and Exercise Biology
Deshmukh, A. S. (2016) · Proteomes · doi:10.3390/proteomes4010006 · Cited by 35
“Impairments in insulin action in skeletal muscle have been clearly established as one of the early and primary defects in the pathogenesis of Type 2 diabetes [2–4].”
BackgroundOrtmeyer, H. K., Bodkin, N. L., & HANSEN, B. C. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.1.e133 · Cited by 33
Medium-Chain, Even-Numbered Dicarboxylic Acids as Novel Energy Substrates: An Update
Mingrone, G., & Castagneto, M. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00175.x · Cited by 33
Glycogen synthase: a putative locus for diet-induced hyperglycemia.
Seldin, M. F., Mott, D. M., Bhat, D., Petro, A., Kuhn, C. M., Kingsmore, S. F., Bogardus, C., Opara, E. C., Feinglos, M. N., & Surwit, R. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117317 · Cited by 33
Introduction???Preventing Insulin Resistance through Exercise: A Cellular Approach
Hawley, J. A., & Houmard, J. A. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000132382.95142.71 · Cited by 33
Ebeling, P. R., & Koivisto, V. A. (1994) · Diabetologia · doi:10.1007/s001250050094 · Cited by 33
“11), caused either by allosteric regulators or covalent modification regulate glycogen synthesis [9].”
BackgroundHenriksen, J. E., Levin, K., Thye‐Rønn, P., ALFORD, F. P., Nielsen, O. H., Holst, J. J., & Beck‐Nielsen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1209 · Cited by 33
“The reduction of Rd in the relatives at low insulin levels and at euglycemia was due to a decreased peripheral GS (calculated from the tritiated water counts) and a decreased nonoxidative glucose metabolism (calculated from the calorimetry data), which is in agreement with earlier studies using higher clamp insulin le…”
BackgroundMethodResultInfluentialSelf-citationKeapai, W., Apichai, S., Amornlerdpison, D., & Lailerd, N. (2016) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2016.20.6.581 · Cited by 32
“Type 2 diabetes mellitus (T2DM) is the most common form of diabetes mellitus.”
BackgroundInfluentialChronic Calorie Restriction Alters Glycogen Metabolism in Rhesus Monkeys
Ortmeyer, H. K., Bodkin, N. L., & HANSEN, B. C. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00104.x · Cited by 32
Sandqvist, M., Eriksson, J. W., & Jansson, P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2344 · Cited by 31
13 C/ 31 P NMR studies of glucose transport in human skeletal muscle
Roussel, R., Carlier, P. G., Robert, J., Velho, G., & Bloch, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1313 · Cited by 30
Piatti, P., Monti, L. D., Davis, S. N., Conti, M., Brown, M. D., Pozza, G., & Alberti, K. G. M. M. (1996) · Diabetologia · doi:10.1007/bf00400420 · Cited by 31
“glycogen synthesis) in lean NIDDM subjects after acipimox could be related to an intrinsic defect in glycogen synthesis, which is independent of NEFA levels [34] and triglyceride levels.”
BackgroundIkonomidis, I., Lambadiari, V., Pavlidis, G., Koukoulis, C., Kousathana, F., Varoudi, M., Spanoudi, F., Maratou, E., Parissis, J., Triantafyllidi, H., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.006 · Cited by 30
Kuroyama, H., Sanke, T., Ohagi, S., Furuta, M., Furuta, H., & Nanjo, K. (1994) · Diabetologia · doi:10.1007/s001250050144 · Cited by 30
“Several recent studies have demonstrated reduced insulin-stimulated glycogen synthase activity in skeletal muscle of patients with NIDDM [5, 6] and their firstdegree relatives [7].”
BackgroundBeck‐Nielsen, H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2337 · Cited by 30
“has later on been confirmed in several publications and also demonstrated in cultured myotubes from T2D subjects and in first-degree relatives of T2D subjects [9,16,26,35].”
BackgroundResultInfluentialSelf-citationPontiroli, A. E., Monti, L. D., Pizzini, A., & Piatti, P. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1359 · Cited by 30
Poulsen, P., Wojtaszewski, J. F. P., Petersen, I., Christensen, K., Richter, E. A., Beck‐Nielsen, H., & Vaag, A. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1289 · Cited by 28
“The lack of any significant heritability of total and fractional muscle GS enzyme activity per se found in this study may to some extent question the view from studies in first-degree relatives (4,10) and from human muscle cell culture studies in type 2 diabetic patients (11) of a genetic defect in this enzyme underly…”
BackgroundResultSelf-citationPathophysiology of non-insulin-dependent diabetes mellitus (NIDDM)
Beck‐Nielsen, H., Henriksen, J. E., Vaag, A. A., & Nielsen, O. H. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01082-o · Cited by 28
Self-citationO'Doherty, R. M., Halseth, A. E., Granner, D. K., Bracy, D. P., & Wasserman, D. H. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.2.e287 · Cited by 28
“Results obtained in human skeletal muscle, which contains both fast- and slow-twitch muscles, support the findings of the present study by showing that glucose concentration either falls slightly or stays the same during a hyperinsulinemic, euglycemic clamp (24, 51, 55, 57).”
ResultAndrogens, the Metabolic Syndrome, and Non–Insulin‐Dependent Diabetes Mellitus
Björntorp, P. A. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb38738.x · Cited by 28
Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23
Dunn, J. S., Mlynarski, W. M., Pezzolesi, M. G., Borowiec, M., Powers, C. M., Królewski, A. S., & Doria, A. (2006) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2005.00248.x · Cited by 27
“…of its gene product as a critical regulator of glycogen synthase (Doherty et al. 1995; Munro et al. 2002), and the observation that type 2 diabetic patients are characterized by a decreased rate of glycogen synthesis in skeletal muscle in response to insulin (Shulman et al. 1990; Vaag et al. 1992).”
BackgroundInfluentialHamley, S., Kloosterman, D., Duthie, T., Man, C. D., VISENTIN, R., Mason, S. A., Ang, T., Selathurai, A., Kaur, G., Morales-Scholz, M. G., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-04990-y · Cited by 30
Damm, P., Vestergaard, H., Kühl, C., & Pedersen, O. B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70456-8 · Cited by 27
Hart, L. M. ‘., Stolk, R. P., Heine, R. J., Grobbee, D. E., Does, F. E. E. V. D., & Maassen, J. A. (1996) · PubMed Central · Cited by 27
Pill, J., & Kühnle, H. F. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90007-0 · Cited by 27
Choi, C. S., Lee, F. N., & Youn, J. H. (2001) · Diabetes · doi:10.2337/diabetes.50.2.418 · Cited by 25
Ortmeyer, H. K., Bodkin, N. L., & HANSEN, B. C. (1993) · Diabetologia · doi:10.1007/bf00399950 · Cited by 27
“Additionally, prior reports have found an absence of [22] or reduced insulin action on skeletal muscle glycogen synthase from insulin-resistant humans [24, 25] and monkeys [23] and in first degree relatives of Type 2 diabetic patients [26].”
BackgroundHegele, R. A., Harris, S. B., Zinman, B., Wang, J., Cao, H., Hanley, A. J., Tsui, L., & Scherer, S. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5219 · Cited by 27
Rissanen, J., Pihlajamäki, J., Heikkinen, S., Kekäläinen, P., Mykkänen, L., Kuusisto, J., Kolle, Å., & Laakso, M. (1997) · Diabetologia · doi:10.1007/s001250050826 · Cited by 26
“activity of GS in normoglycaemic first-degree relatives of NIDDM patients [7, 14].”
BackgroundGelding, S. V., Niththyananthan, R., Chan, S.-P., Skinner, E., Robinson, S., Gray, I. P., Mather, H. M., & Johnston, D. G. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02443.x · Cited by 26
Insulin resistance in non-insulin-dependent diabetes mellitus
Alzaid, A. (1996) · Acta Diabetologica · doi:10.1007/bf00569416 · Cited by 25
Damsbo, P., Hermann, L. S., Vaag, A. A., Nielsen, O. H., & Beck‐Nielsen, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1489 · Cited by 25
“Its activity is reduced in NIDDM (1-3) and in nondiabetic subjects with insulin resistance (1,4,5).”
BackgroundSelf-citationGrunnet, L. G., Poulsen, P., Pedersen, B. K., Mandrup-Poulsen, T. R., & Vaag, A. A. (2005) · Diabetologia · doi:10.1007/s00125-005-0080-8 · Cited by 24
“of metabolism in patients with overt type 2 diabetes, hepatic glucose production is commonly normal in insulinresistant prediabetic subjects [37, 38], and is therefore considered a ‘secondary’ or non-genetic defect of metabolism in type 2 diabetes [19].”
BackgroundSelf-citationGoto, H., & Takamura, T. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25017 · Cited by 28
“50,51 Moreover, observational studies have shown that glycogen synthesis in skeletal muscle is reduced in elderly individuals, compared with younger ones, whereas hepatic de novo lipogenesis is enhanced.”
Advances in molecular imaging of pancreatic beta cells
redefined, N. (2008) · Frontiers in bioscience · doi:10.2741/3023 · Cited by 23
PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.010 · Cited by 23
Ortmeyer, H. K., Bodkin, N. L., HANSEN, B. C., & Larner, J. (1995) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(95)00080-j · Cited by 23
Prediabetes and perinatal mortality.
Wood, S., Sauvé, R., Ross, S., Brant, R., & Love, E. J. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1752 · Cited by 23
Hansen, L., Reneland, R., Berglund, L., Rasmussen, S. K., Hansen, T., Lithell, H., & Pedersen, O. (2000) · Diabetes · doi:10.2337/diabetes.49.2.298 · Cited by 22
Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes
Monti, L. D., Valsecchi, G., Costa, S., Sandoli, E. P., Phan, C. V., Pontiroli, A. E., & Piatti, P. M. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90763-7 · Cited by 22
High expression of CPT1b in skeletal muscle in metabolically healthy older subjects
Betry, C., Meugnier, E., Pflieger, M., Grenet, G., Herçberg, S., Galan, P., Kesse‐Guyot, E., Vidal, H., & Laville, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.018 · Cited by 21
Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus
Perriello, G., Misericordia, P., Volpi, E., Pampanelli, S., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629243 · Cited by 21
3 The Genetics of Non-insulin-Dependent Diabetes Mellitus
Pillay, T. S., Langlois, W. J., & Olefsky, J. M. (1995) · Advances in genetics · doi:10.1016/s0065-2660(08)60203-5 · Cited by 20
Kumar, K. L. A., & Marita, A. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703313 · Cited by 19
“In subjects with a family history of NIDDM, insulin resistance on glycogen synthesis occurs before the development of overt diabetes (Schalin-Jantti et al., 1992; Vaag et al., 1992).”
BackgroundThe pathogenesis of NIDDM: the role of the pancreatic beta cell
Zawalich, W. S., & Kelley, G. G. (1995) · Diabetologia · doi:10.1007/bf00400590 · Cited by 20
“Consistent with the concept that insulin resistance is the primal manifestation of developing diabetes, or the prediabetic state, are several recently published reports [6-8].”
BackgroundRegulation of Muscle Glucose Uptake In Vivo
Mandarino, L. J., Bonadonna, R. C., McGuinness, O. P., Halseth, A. E., & Wasserman, D. H. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070227 · Cited by 19
Nielsen, M. F., Nyholm, B., Caumo, A., Chandramouli, V, Schumann, W. C., Cobelli, C., Landau, B. R., Rizza, R. A., & Schmitz, O. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2135 · Cited by 25
Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome
Anthanont, P., Ramos, P. A., Jensen, M. D., & Hames, K. C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.171 · Cited by 19
Effects of Troglitazone in Young First-Degree Relatives of Patients With Type 2 Diabetes
Levin, K., Nielsen, O. H., Henriksen, J. E., & Beck‐Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.148 · Cited by 18
“Glucose and lipid oxidation Indirect calorimetry was performed using a computerized flow-through canopy gas analyzer system (Deltatrac; Datex, Helsinki, Finland), as previously described (4).”
MethodSelf-citationThe Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans
Sales, V., & Patti, M. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0283-8 · Cited by 17
Doney, A. S. F., Fischer, B., Cecil, J. E., Cohen, P. T. W., Boyle, D. I., Leese, G., Morris, A. D., & Palmer, C. N. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-11 · Cited by 16
“Glycogen-synthase (GS) catalyses one of the rate-determining steps in glycogen synthesis in muscle and defective insulin-mediated activation of muscle GS has been found in glucose tolerant, but insulin resistant first-degree relatives of Caucasian type 2 diabetic patients [3].”
BackgroundGenetic epidemiology of non‐insulin‐dependent diabetes
Valsania, P., & Micossi, P. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100404 · Cited by 16
Amador, M. J., Meza, C., McAinch, A. J., King, G. A., Covington, J. D., & Bajpeyi, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00120 · Cited by 17
Sonne, M. P., Højbjerre, L., Alibegovic, A. C., Vaag, A. A., Stallknecht, B. M., & Dela, F. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.011 · Cited by 15
Self-citationZhang, S., Chen, P., Jin, H., Yi, J., Xie, X., Yang, M., Gao, T., Yang, L., Hu, C., Zhang, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03271-1 · Cited by 15
Jeppesen, J. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903321648243 · Cited by 16
“…syndrome X. 21,65 Several family studies have shown that healthy, non-diabetic, normotensive relatives to patients with one or more of the following diagnoses: type-2 diabetes, 66,76,77 hypertension, 78–80 and IHD, 81 are relatively more insulin resistance and/or hyperinsulinemic and dyslipidemic.”
Physical Activity and Insulin Resistance in Man
Dela, F., Mikines, K. J., & Galbo, H. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_6 · Cited by 14
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Polymorphism of the Glycogen Synthase Gene in Hypertensive and Normotensive Subjects
Schalin‐Jäntti, C., Nikula-Ijäs, P., Huang, X., Lehto, M. J., Knudsen, P., Syvänne, M., Lehtovirta, M., Tikkanen, T., Tikkanen, I. T., & Groop, L. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.67 · Cited by 15
Songtrai, S., Pratchayasakul, W., Arunsak, B., Chunchai, T., Kongkaew, A., Chattipakorn, N., Chattipakorn, S. C., & Kaewsuwan, S. (2022) · Nutrients · doi:10.3390/nu14224895 · Cited by 14
Solini, A., Virgilio, F. D., Chiozzi, P., Fioretto, P., Passaro, A., & Fellin, R. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1492 · Cited by 14
Metadata
- Authors
- Vaag, A., Henriksen, J. E., & Beck-Nielsen, H.
- Affiliations
- Odense University Hospital (DK)
- Venue
- Journal of Clinical Investigation
- Published
- 1992-03-01
- Volume
- 89
- Issue
- 3
- Pages
- 782-788
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC442922
- OpenAlex
- W2041249629
- Cited by
- 299
- References
- 58
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 7 · 2017: 2 · 2016: 5 · 2015: 6 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetesforeningen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- insulin resistance, type 2 diabetes, glycogen synthase, skeletal muscle, first-degree relatives, genetic susceptibility, insulin-stimulated glucose disposal, nonoxidative glucose metabolism, muscle glycogen, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Enzyme Activation, Glycogen Synthase, Humans, Insulin, Insulin Resistance, Muscles, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review